alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



Exhibit 31.2 CERTIFICATION BY CHIEF FINANCIAL OFFICER
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Carmen L. Diersen, certify that: 1. I have reviewed this quarterly report on Form 10-Q of American Medical
Systems Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant
as of, and for, the periods presented in this report; 4. The registrants other certifying officer(s) and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: (a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the registrant, including
its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being
prepared; (b) Evaluated the effectiveness of the registrants disclosure controls
and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures, as of the end of
the period covered by this report based on such evaluation; and (c) Disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the registrants
most recent fiscal quarter that has materially affected, or is reasonably
likely to materially affect, the registrants internal control over
financial reporting; and 5. The registrants other certifying officer and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrants auditors and the audit committee of the registrants board of
directors (or persons performing the equivalent function): (a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrants ability to record,
process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrants internal
control over financial reporting.  Date: November 12, 2004
    By:
    /s/  Carmen L. DiersenName:
    Carmen L. DiersenTitle:
    Executive Vice President and
Chief Financial Officer
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 364 Introduced in House (IH)]

113th CONGRESS
  1st Session
H. RES. 364

    Supporting the goals and ideals of ``World Alzheimer's Month''.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           September 27, 2013

 Mr. Fattah submitted the following resolution; which was referred to 
                  the Committee on Energy and Commerce

_______________________________________________________________________

                               RESOLUTION

 
    Supporting the goals and ideals of ``World Alzheimer's Month''.

Whereas Alzheimer's is a progressive neurological disease that impairs an 
        individual's memory, cognitive abilities, and behavior;
Whereas Alzheimer's is the most common form of dementia;
Whereas approximately 35,600,000 individuals cope with dementia worldwide, with 
        more than 5,000,000 living with Alzheimer's in the United States;
Whereas neurological research continues to lead to advances in the treatment and 
        diagnosis of Alzheimer's and other forms of dementia; and
Whereas ``World Alzheimer's Month'' is recognized in September and serves to 
        increase awareness about the disease, its impact on the lives of those 
        affected by it, and the efforts of those seeking to cure Alzheimer's: 
        Now, therefore, be it
    Resolved, That the House of Representatives--
            (1) supports the goals and ideals of ``World Alzheimer's 
        Month'';
            (2) acknowledges the impact Alzheimer's has on the lives of 
        individuals worldwide and in the United States; and
            (3) acknowledges the progress and improvements neurological 
        research has made in the diagnosis and treatment of Alzheimer's 
        and other forms of dementia.
                                 <all>
```
March 8, 2012

JUDGMENT

The Fourteenth Court of Appeals

8100 NORTH FREEWAY, LTD., Appellant

NO. 14-11-00301-CV V.

THE CITY OF HOUSTON, Appellee

____________________

This cause, an appeal from the judgment in favor of appellee, the City of Houston, 

signed March 24, 2011, was heard on the transcript of the record. We have inspected the 

record and find no error in the judgment. We order the judgment of the court below 

AFFIRMED.

We order appellant, 8100 North Freeway, Ltd., to pay all costs incurred in this 

appeal. We further order this decision certified below for observance.
<PAGE>


                                               FARMERS & MERCHANTS SEC FORM 8-K.
                                                                       EXHIBIT 3


                  AMENDMENT TO THE ARTICLES OF INCORPORATION OF

                        FARMERS & MERCHANTS BANCORP, INC.

FOURTH. The number of shares which the Corporation is authorized to have
outstanding is 6,500,000 shares all of which shall be common shares, without par
value (the "Shares."). The holders of the Shares are entitled at all times,
except in the election of directors where the Shares may be voted cumulatively,
to one (1) vote for each Share and to such dividends as the Board of Directors
(herein called the "Board") may in its discretion periodically declare. In the
event of any liquidation, dissolution or winding up of the Corporation, the
remaining assets of the Corporation after the payment of all debts and necessary
expenses shall be distributed among the holders of the Shares pro rata in
accordance with their respective Share holdings.

NINTH. Except as otherwise required by these Articles and notwithstanding any
provision of law requiring any greater affirmative vote, any amendments to these
Articles may be made, by the affirmative vote of the holders of 66 2/3% of the
total number of shares voted with respect to such proposed amendment, including
for the purposes of this Article NINTH shares voted for, against or abstain, but
excluding any shares not voted, provided however, that the total number of
shares voted in favor of the amendment represent at least a simple majority of
the total voting power of the Corporation. In addition to the foregoing voting
requirements, any amendment of these Articles that is inconsistent with, or
would have the effect of altering or repealing the provisions of Article SIXTH
of the Corporation's Articles of Incorporation shall require the affirmative
vote of the holders of Shares that would be required to approve a transaction
under the provisions of Article SIXTH.
##### 



Exhibit 99.2
 
 CONTACT:
    Michal D. Cann
Rick A. Shields
360.679.312
    President & CEO
SVP & CFO
    
    CORPORATE INVESTOR RELATIONS
5333  15TH AVENUE SOUTH, SUITE 1500
SEATTLE, WA 98108
206.762.0993
www.stockvalues.com
    WASHINGTON BANKING COMPANY INCREASES CASH DIVIDEND BY 14%
    This news release may contain forward-looking statements that are subject to risks and
uncertainties. These forward-looking statements describe managements expectations regarding
future events and developments such as future operating results, growth in loans and deposits, the
capability to continue to pay cash and stock dividends, and continued success of the Companys
business plan. Readers should not place undue reliance on forward-looking statements, which
reflect managements views only as of the date hereof. Future events are difficult to predict, and
the expectations described above are subject to risk and uncertainty that may cause actual results
to differ materially. In addition to discussions about risks and uncertainties set forth from time
to time in the Companys filings with the Securities and Exchange Commission, factors that may
cause actual results to differ materially from those contemplated in these forward-looking
statements include, among others: (1) local and national general and economic condition; (2)
unexpected changes in interest rates and their impact on net interest margin; (3) competitive
pressure among financial institutions; (4) legislation or regulatory requirement; and (5) the
ability to realize the efficiencies expected from investment in personnel and infrastructure.
Washington Banking Company does not undertake to update forward-looking statements to reflect
circumstances or events that occur after the date the forward-looking statements were made. Any
such statements are made in reliance on the safe harbor protections provided under the Securities
Exchange Act of 1934, as amended.
 www.wibank.com
##### 



EXHIBIT 32

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of NRG Northeast Generating LLC (the
Company) on Form 10-Q for the quarter ended September 30, 2003, as filed with
the Securities and Exchange Commission on the date hereof (Form 10-Q), each of
the undersigned officers of the Company certifies, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to such officers knowledge:



|(1) |  | The Form 10-Q fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and
|--- |  | ------------------------------------------------------------------------------------------------------------------------



|(2) |  | The information contained in the Form 10-Q fairly presents, in all
material respects, the financial condition and results of operations of
the Company as of the dates and for the periods expressed in the Form
10-Q.
|--- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: November 13, 2003

/s/ Scott J. Davido

Scott J. Davido,
Vice President
(Principal Executive Officer)/s/ George P. Schaefer

George P. Schaefer, Treasurer
(Principal Financial Officer)/s/ William T. Pieper

William T. Pieper, Controller
(Principal Accounting Officer)


The foregoing certification is being furnished solely pursuant to 18 U.S.C.
Section 1350 and is not being filed as part of the Report or as a separate
disclosure document.

A signed original of this written statement required by Section 906, or other
document authenticating, acknowledging or otherwise adopting the signature that
appears in typed form within the electronic version of this written statement
required by Section 906, has been provided to NRG Northeast Generating LLC and
will be retained by NRG Northeast Generating LLC and furnished to the
Securities and Exchange Commission or its staff upon request.

39
## Breadcrumb

-  Home 

# Explore Search: Floods

Filters

              - science_science(4)
              - products_publications(17)
              - products_web_tools(1)
              - multimedia_video(9)
              - multimedia_video-149195(9)
              - (-)news_news-149245(1)
              - news_news-149248(2)
              - news_other_news(1)
              - connect_staff_profiles(1)
              - other_basic-42(3)

## By Location

              - alaska(1)
              - arizona(4)
              - arkansas(2)
              - california(5)
              - colorado(6)
              - connecticut(1)
              - (-)delaware(1)
              - florida(3)
              - georgia(3)
              - guam(1)
              - hawaii(2)
              - idaho(2)
              - illinois(1)
              - indiana(3)
              - iowa(7)
              - kansas(1)
              - louisiana(1)
              - maine(2)
              - massachusetts(1)
              - michigan(1)
              - minnesota(3)
              - missouri(5)
              - montana(2)
              - nebraska(2)
              - nevada(2)
              - new hampshire(2)
              - new jersey(2)
              - new mexico(2)
              - new york(2)
              - north carolina(3)
              - north dakota(4)
              - ohio(3)
              - oklahoma(4)
              - oregon(3)
              - pennsylvania(1)
              - puerto rico(1)
              - rhode island(1)
              - south carolina(5)
              - south dakota(7)
              - texas(12)
              - u.s. virgin islands(1)
              - utah(1)
              - vermont(1)
              - virginia(2)
              - washington(3)
              - west virginia(1)
              - wyoming(1)

## By Year

State News Release        March 1, 2018        USGS Deploys Storm-Tide Sensors in Advance of Nor’Easter
N OTE : This o rder is non precedential.


# United States **Court of Appeals**  **for the Federal Circuit**

______________________

MARINE TRAVELIFT INC
., Plaintiff

- Appellant,

v.

ASCOM SPA AND INTERNATIONAL BOATLI FT EXCHANGE INC
., Defendants

- Appellees.

______________________

2014

- 1810

______________________
Appeal from the United States District Court for the Eastern District of Wisconsin in No. 1:14

- cv

- 00443

- WCG, Judge William C. Griesbach.

______________________

ON MOTION

______________________

O R D E R

Marine Travelift Inc. moves without opposition to vo luntarily dismiss this appeal.

Upon consideration thereof,

I T I S O RDERED T HAT : (1) The motion is granted. The appeal is dismissed. Case: 14-1810 Document: 17 Page: 1 Filed: 11/20/2014MARINE TRAVELIFT INC

. v. ASCOM SPA 2

(2) Each side shall bear its own costs.

F OR THE C OURT

/s/ Daniel E. O’Toole Daniel E. O’Toole Clerk of Court

s21

ISSUED AS A MANDATE: November 20, 2014 Case: 14-1810 Document: 17 Page: 2 Filed: 11/20/2014
Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Genesis HealthCare Corporation:

We    consent to the incorporation by reference in the registration statements    (No. 333–111188, No. 333–111189, and No. 333–111190) on Form    S-8 and (No. 333–126180) on Form S-3, as amended, of Genesis HealthCare    Corporation of our reports dated December 13, 2006, with respect to the consolidated    balance sheets of Genesis HealthCare Corporation and subsidiaries as of September    30, 2006 and 2005, and the related consolidated statements of operations,    shareholders’ equity and cash flows for each of the years in the three-year    period ended September 30, 2006, and the related financial statement schedule,    management’s assessment of the effectiveness of internal control over    financial reporting as of September 30, 2006 and the effectiveness of internal    control over financial reporting as of September 30, 2006, which reports    appear in the September 30, 2006 annual report on  Form 10-K of Genesis HealthCare    Corporation.

Our  report on the consolidated financial statements and related financial statement  schedule contains an explanatory paragraph that states that Genesis HealthCare  Corporation adopted Statement of Financial Accounting Standards No. 123(R),  *Share Based Payment*,  and related interpretations on October 1, 2005 and also adopted Financial Accounting  Standards Board Interpretation No. 47, *Accounting  for Conditional Asset Retirement Obligations*,  and recognized the impact of the adoption as a cumulative effect of an accounting  change for the year ended September 30, 2006.

|                                        |   |   |   |
|---------------------------------------------|--------|--------|--------|
| /s/ KPMG LLP                                |   |   |        |
| Philadelphia, PennsylvaniaDecember 13, 2006 |   |   |   |

----
**Exhibit 31.2**
 **CERTIFICATION OF PERIODIC REPORT PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**
 
 I, Ron Bentsur, certify that:
 
 1.
I have reviewed this quarterly report on Form 10-Q of Keryx Biopharmaceuticals, Inc.; 
 2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 
 3.
Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 
 4.
The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 
 a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; 
 b)
[Paragraph omitted in accordance with SEC transition instructions contained in SEC Release 34-47986] 
 c)
Evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 
 d)
Disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting; and 
 5.
The registrants other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of the registrants board of directors (or persons performing the equivalent functions): 
 a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information; and 
 b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting. 
 Date: November 11, 2004

/s/ Ron BentsurRon Bentsur
Vice President, Finance and Investor Relations
(Principal Financial and Accounting Officer)
**Exhibit 31.1**
**Certification of Chief Executive Officer under Section 302(a) of the Sarbanes-Oxley Act of 2002**
I, Lissa A. Goldenstein, President and Chief Executive Officer of Argonaut Technologies, Inc.,certify that:
1.  I have reviewed this annual report on Form 10-K of Argonaut Technologies, Inc.;
2.  Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report;
3.  Based on my knowledge, the financial statements, and other financial information included inthis report, fairly present in all material respects the financial condition, results ofoperations and cash flows of the registrant as of, and for, the periods presented in thisreport;
4.  The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:
 a)  Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including its consolidated subsidiaries, is madeknown to us by others within those entities, particularly during the period in whichthis report is being prepared;  b)  Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by this reportbased on such evaluation; and  c)  Disclosed in this report any change in the registrant’s internal control over thefinancial reporting that occurred during the registrant’s most recent fiscal quarter(the registrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, the registrant’sinternal control over financial reporting: and
5.  The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing the equivalentfunctions):
 a)  All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely to adverselyaffect the registrant’s ability to record, process, summarize and report financialinformation; and  b)  Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.
Date: April 15, 2005
**/s/ LISSA A. GOLDENSTEIN**